Making Invisible Illnesses Visible: Recognizing and Responding to Infection-Associated Chronic Conditions

Area of Science:

• Infectious Diseases
• Immunology
• Public Health

Background:

• Post-COVID conditions (PCC) have increased focus on infection-associated chronic conditions and illnesses (IACCI).
• Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Lyme disease-associated chronic symptoms are examples of debilitating IACCI.
• These conditions share similar symptoms and underlying pathophysiologic abnormalities, yet receive inadequate clinical attention and research funding.

Purpose of the Study:

• To outline a patient-centered approach for managing IACCI.
• To identify opportunities for improving clinical practice and research investment in IACCI.
• To leverage advances in PCC and ME/CFS research for developing targeted therapies.

Main Methods:

• Review of existing literature on PCC, ME/CFS, and Lyme disease.
• Analysis of current clinical care models and research funding for IACCI.
• Proposal of a patient-centered care framework emphasizing validation, multidisciplinary management, and symptom-focused treatment.

Main Results:

• A patient-centered approach can improve care through validation, multidisciplinary management, and symptom-focused treatment.
• Opportunities for strengthening clinical practice include new CMS codes, extended visits, and improved care environments.
• Advances in PCC and ME/CFS research offer a basis for exploring shared mechanisms and developing therapies.

Conclusions:

• Coordinated action among clinicians, researchers, and policymakers is essential to address gaps in IACCI care.
• Improved surveillance, harmonized research, and inclusive trial designs are needed to understand disease burden and accelerate therapeutic progress.
• Implementing a patient-centered approach and investing in research can significantly improve outcomes for individuals with IACCI.